Equilibar has released a single use pressure control valve for biopharma and other markets. The valve was officially introduced April 17, 2018 at the InterPhex BioPharma trade show in New York City.
This specialty instrument was developed in response to the biopharma industry’s rapidly expanding requirements for low cost components that can be sterilized through radiation and disposed of after use. It is also appropriate for other service conditions that require single use components.
The valve’s patent pending design offers USP Class VI polymers that can be sterilized as an assembly. Only the wetted components and diaphragm are disposable and are inserted into a permanent stainless steel support housing for quick and easy assembly. The Single Use Equilibar features the same dome-loaded multiple orifice technology as all Equilibar patented products, delivering instantaneous control, frictionless operation, superior precision, and exceptionally wide flow rate ranges. Its strengths are particularly well suited to control the transmembrane pressure in tangential flow filtration control applications.
“We’re excited about the potential for the Single Use Equilibar to bring our revolutionary technology to many more markets,” said Design Engineer Ryan Heffner, who specializes in biopharma applications as well as other complex pressure control applications. “Equilibar® back pressure regulators and vacuum control valves operate in a completely different way than traditional pressure control products, and we’re excited to bring our technology into a new sphere.”
For more information, visit https://www.equilibar.com/application/single-use-control-valve/ or contact an application engineer at firstname.lastname@example.org.